Sorafenib therapy for hepatocellular carcinoma in an HIV-HCV coinfected patient: a case report.
about
A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi Sarcoma.Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.Treatment of Recurrent Hepatocellular Carcinoma with Sorafenib in a HIV/HCV Co-Infected patient in HAART: A Case Report.Amprenavir inhibits the migration in human hepatocarcinoma cell and the growth of xenografts.
P2860
Sorafenib therapy for hepatocellular carcinoma in an HIV-HCV coinfected patient: a case report.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Sorafenib therapy for hepatoce ...... fected patient: a case report.
@en
Sorafenib therapy for hepatoce ...... fected patient: a case report.
@nl
type
label
Sorafenib therapy for hepatoce ...... fected patient: a case report.
@en
Sorafenib therapy for hepatoce ...... fected patient: a case report.
@nl
prefLabel
Sorafenib therapy for hepatoce ...... fected patient: a case report.
@en
Sorafenib therapy for hepatoce ...... fected patient: a case report.
@nl
P2093
P2860
P1433
P1476
Sorafenib therapy for hepatoce ...... fected patient: a case report.
@en
P2093
Alberto Tagliani
Alfredo Scalzini
Barbara Morandini
Enrico Aitini
Giorgio Perboni
Giovanni Carlo Fibbia
Paolo Costa
Rita Cengarle
P2860
P304
P356
10.1634/THEONCOLOGIST.2010-0010
P577
2010-02-08T00:00:00Z